SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25

SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25 Share Price

DE000SW7K5H5

Market Closed - Boerse Frankfurt Warrants 01:08:10 25/05/2024 am IST
2.5 ^EUR	-1.57%

Current month	+79.43%
1 month	+158.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	22/05	AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	21/05	BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	21/05	AQ
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	21/05	CI

More news

Quotes 5-day view

Date	Price	Change
24/24/24	2.53	-0.39%
23/24/23	2.54	-4.87%
22/24/22	2.67	+8.10%
21/24/21	2.47	-1.59%
20/24/20	2.51	+10.09%

Real-time Boerse Frankfurt Warrants

Last update May 25, 2024 at 01:08 am IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Société Générale
WKN	SW7K5H
ISIN	DE000SW7K5H5
Date issued	12/03/2024
Strike	17 $
Maturity	21/03/2025 (301 Days)
Parity	1 : 1
Emission price	1.28 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.75 €
Lowest since issue	0.78 €
Spread	0.02 €
Spread %	0.80%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company